Value of preoperative serum CA125 in early-stage adenocarcinoma of the uterine cervix without pelvic lymph node metastasis (Q81484688)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290001%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Value of preoperative serum CA125 in early-stage adenocarcinoma of the uterine cervix without pelvic lymph node metastasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290001%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

main subject

cervical adenocarcinoma

1 reference

Ching-Chou Tsai

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290001%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Yi-Shan Liu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290001%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Eng-Yen Huang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290001%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Shun-Chen Huang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290001%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Hsueh-Wen Chang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290001%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Chih-Weng Tseng

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290001%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Chan-Chao ChangChien

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290001%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

10 November 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290001%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290001%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290001%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290001%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

591-595

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290001%20AND%20SRC:MED&resulttype=core&format=json

The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Serum CA 125 is an independent prognostic factor in cervical adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Serum CA125 regression in epithelial ovarian cancer: correlation with reassessment findings and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Preoperative CA 125 levels: an independent prognostic factor for epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Comparison between squamous cell carcinoma-associated antigen and CA-125 in patients with carcinoma of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Tumor markers CA 125, carcinoembryonic antigen and tumor-associated trypsin inhibitor in patients with cervical adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Tumor antigens CA 19.9, CA 125, and CEA in carcinoma of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

What is a normal CA125 level?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Prognostic factors associated with radical hysterectomy failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Is lymph vascular space involvement an independent prognostic factor in early cervical cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Does the density of lymphatic vascular space invasion affect the prognosis of stage Ib and IIA node negative carcinoma of the cervix?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Invasive cervical carcinoma: comparison of MR imaging and surgical findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Imaging in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Prognostic factors in adenocarcinoma of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

Stage IB squamous cancer of the cervix: the choice of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.049

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2005.09.049

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16290001%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference